Ursodiol Tablet, Film Coated
Product Images NDC 55154-2633

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 55154-2633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg Bag Label (61dcaec8 3acb 4ef0 Afde 65a66e99afa7 00)

Drug facts panel for Ursodiol tablets USP 250 mg, containing information on dosage, storage, warnings, and distribution. The label notes usage instructions, storage temperature (20° to 25°C), and that the unit dose package is not child-resistant. It includes manufacturer details from India and Italy, and distribution information for Major Pharmaceuticals and Cardinal Health.*

FDA Label Image

Ursodiol-structure.jpg (Ursodiol Tablet 1)

Chemical structure diagram of Ursodiol, the active ingredient in Ursodiol 250 mg oral tablets by Cardinal Health 107, LLC. The structure shows the arrangement of carbon, hydrogen, and oxygen atoms characteristic of Ursodiol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.